Cargando…
Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy
Autoimmune hepatitis (AIH) is an immune mediated liver injury. The precise aetiology of AIH is still unknown but current evidence suggests both genetic and environmental factors are involved. Breakdown in peripheral self-tolerance, and impaired functions of FOXP3(+) regulatory T cell along with effe...
Autores principales: | Than, Nwe Ni, Jeffery, Hannah C., Oo, Ye H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4904688/ https://www.ncbi.nlm.nih.gov/pubmed/27446862 http://dx.doi.org/10.1155/2016/7181685 |
Ejemplares similares
-
Corrigendum to “Autoimmune Hepatitis: Progress from Global Immunosuppression to Personalised Regulatory T Cell Therapy”
por: Than, Nwe Ni, et al.
Publicado: (2016) -
Difference in clinical presentation, immunology profile and treatment response of type 1 autoimmune hepatitis between United Kingdom and Singapore patients
por: Than, Nwe Ni, et al.
Publicado: (2016) -
Changes in natural killer cells and exhausted memory regulatory T Cells with corticosteroid therapy in acute autoimmune hepatitis
por: Jeffery, Hannah C., et al.
Publicado: (2018) -
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group
por: Than, Nwe Ni, et al.
Publicado: (2019) -
Clinical Potential of Regulatory T Cell Therapy in Liver Diseases: An Overview and Current Perspectives
por: Jeffery, Hannah C., et al.
Publicado: (2016)